Upstream Bio (UPB) Net Income towards Common Stockholders: 2023-2025
Historic Net Income towards Common Stockholders for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -$33.7 million.
- Upstream Bio's Net Income towards Common Stockholders fell 60.45% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.8 million, marking a year-over-year decrease of 76.43%. This contributed to the annual value of -$76.4 million for FY2024, which is 99.70% down from last year.
- Per Upstream Bio's latest filing, its Net Income towards Common Stockholders stood at -$33.7 million for Q3 2025, which was up 15.56% from -$40.0 million recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Net Income towards Common Stockholders ranged from a high of -$6.3 million in Q3 2023 and a low of -$40.0 million during Q2 2025.
- In the last 3 years, Upstream Bio's Net Income towards Common Stockholders had a median value of -$21.0 million in 2024 and averaged -$22.1 million.
- Data for Upstream Bio's Net Income towards Common Stockholders shows a maximum YoY crashed of 236.37% (in 2024) over the last 5 years.
- Over the past 3 years, Upstream Bio's Net Income towards Common Stockholders (Quarterly) stood at -$15.0 million in 2023, then tumbled by 45.42% to -$21.8 million in 2024, then plummeted by 60.45% to -$33.7 million in 2025.
- Its last three reported values are -$33.7 million in Q3 2025, -$40.0 million for Q2 2025, and -$27.3 million during Q1 2025.